Stockholm, Sweden

Roland I Jeppsson

This inventor holds 1 USPTO granted patent. Top assignee: Kabivitrum Ab. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roland I Jeppsson. Retrieved from https://idiyas.com/inventor/roland-i-jeppsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Roland I Jeppsson

Introduction

Roland I Jeppsson is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approaches to drug formulation. His work has the potential to impact medical treatments and improve patient care.

Latest Patents

Jeppsson holds a patent for a novel pharmaceutical composition. This composition is designed for intravenous administration of 3-alpha-hydroxy-5-beta-pregnan-20-one, commonly known as pregnanolone. The patent describes a stable oil-in-water emulsion that can be sterilized by autoclaving, containing from 0.1 to 1.0 g of pregnanolone. This innovation represents a significant advancement in the delivery of this important compound.

Career Highlights

Throughout his career, Jeppsson has been associated with Kabivitrum AB, a company that focuses on developing pharmaceutical products. His work at Kabivitrum has allowed him to explore new avenues in drug formulation and delivery systems. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Roland I Jeppsson's contributions to pharmaceutical innovations highlight the importance of research in developing effective medical treatments. His patent for a novel composition demonstrates his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…